Binge-eating disorder treatment goes online - feasibility, usability, and treatment outcome of an Internet-based treatment for binge-eating disorder: study protocol for a three-arm randomized controlled trial including an immediate treatment, a waitlist, and a placebo control group.


Journal

Trials
ISSN: 1745-6215
Titre abrégé: Trials
Pays: England
ID NLM: 101263253

Informations de publication

Date de publication:
13 Feb 2019
Historique:
received: 01 06 2018
accepted: 10 01 2019
entrez: 15 2 2019
pubmed: 15 2 2019
medline: 6 7 2019
Statut: epublish

Résumé

Binge-eating disorder (BED) is characterized by recurrent episodes of loss of control over eating and is related to a higher prevalence of other mental disorders and somatic consequences associated with overweight and obesity. In community-based samples, 2-4% of women and 1-3% men are diagnosed with BED. Psychotherapeutic interventions focusing on maintenance factors of disturbed eating behavior have proven to be effective. However, treatment access is limited for a considerable number of patients with BED. A lack of specialized institutions and treatment resources, but also long distances to treatment facilities for people living in remote or rural areas are often causes of insufficient care. Internet-based guided self-help (GSH) programs have the potential to fill this gap. This project aims to develop and evaluate an Internet-based treatment for BED derived from an evidence-based manualized cognitive behavioral therapy (CBT). The primary goal is to test feasibility and suitability of the Internet-based program and to evaluate the treatment outcome in comparison to a pure and a placebo-inspired waitlist control group (i.e. reduction of binge-eating episodes and eating disorder pathology as primary outcome variables). In total, 60 women and men aged 18-70 years with a BED diagnosis will be recruited. The Internet-based GSH treatment comprises eight sessions followed by three booster sessions. The placebo-inspired waitlist control group receives weekly messages containing information increasing positive expectations regarding the treatment effects during the four-week waiting period. The pure waitlist control group receives weekly messages simply asking patients to fill in a short questionnaire. The access to evidence-based treatments for BED might be made easier using an Internet-based GSH approach. The present study protocol presents a randomized controlled trial. As well as evaluating the suitability and efficacy of the Internet-based GSH treatment, there will also be a prelimarily investigation on the influence of positive expectations (placebo) for a therapeutic intervention on core symptoms. German Clinical Trials Register, DRKS00012355 . Registered on 14 September 2017.

Sections du résumé

BACKGROUND BACKGROUND
Binge-eating disorder (BED) is characterized by recurrent episodes of loss of control over eating and is related to a higher prevalence of other mental disorders and somatic consequences associated with overweight and obesity. In community-based samples, 2-4% of women and 1-3% men are diagnosed with BED. Psychotherapeutic interventions focusing on maintenance factors of disturbed eating behavior have proven to be effective. However, treatment access is limited for a considerable number of patients with BED. A lack of specialized institutions and treatment resources, but also long distances to treatment facilities for people living in remote or rural areas are often causes of insufficient care. Internet-based guided self-help (GSH) programs have the potential to fill this gap.
METHODS METHODS
This project aims to develop and evaluate an Internet-based treatment for BED derived from an evidence-based manualized cognitive behavioral therapy (CBT). The primary goal is to test feasibility and suitability of the Internet-based program and to evaluate the treatment outcome in comparison to a pure and a placebo-inspired waitlist control group (i.e. reduction of binge-eating episodes and eating disorder pathology as primary outcome variables). In total, 60 women and men aged 18-70 years with a BED diagnosis will be recruited. The Internet-based GSH treatment comprises eight sessions followed by three booster sessions. The placebo-inspired waitlist control group receives weekly messages containing information increasing positive expectations regarding the treatment effects during the four-week waiting period. The pure waitlist control group receives weekly messages simply asking patients to fill in a short questionnaire.
DISCUSSION CONCLUSIONS
The access to evidence-based treatments for BED might be made easier using an Internet-based GSH approach. The present study protocol presents a randomized controlled trial. As well as evaluating the suitability and efficacy of the Internet-based GSH treatment, there will also be a prelimarily investigation on the influence of positive expectations (placebo) for a therapeutic intervention on core symptoms.
TRIAL REGISTRATION BACKGROUND
German Clinical Trials Register, DRKS00012355 . Registered on 14 September 2017.

Identifiants

pubmed: 30760299
doi: 10.1186/s13063-019-3192-z
pii: 10.1186/s13063-019-3192-z
pmc: PMC6375147
doi:

Substances chimiques

Placebos 0

Types de publication

Clinical Trial Protocol Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

128

Subventions

Organisme : Swiss Anorexia Nervosa Foundation
ID : 52-15

Références

Br J Psychiatry. 2002 May;180:461-4
pubmed: 11983645
Clin Psychol Rev. 2006 Oct;26(6):657-78
pubmed: 15908088
Biol Psychiatry. 2007 Feb 1;61(3):348-58
pubmed: 16815322
Int J Eat Disord. 2007 Mar;40(2):102-13
pubmed: 17089420
Pediatrics. 2008 Mar;121(3):453-62
pubmed: 18310192
Int J Eat Disord. 2010 Apr;43(3):205-17
pubmed: 19402028
Behav Res Ther. 2009 Jul;47(7):628-35
pubmed: 19446793
J Adolesc Health. 2009 Jul;45(1):95-7
pubmed: 19541256
Psychol Methods. 2010 Sep;15(3):209-33
pubmed: 20822249
Clin Pract Epidemiol Ment Health. 2011 Mar 04;7:8-18
pubmed: 21552482
Behav Res Ther. 2011 Aug;49(8):482-91
pubmed: 21641580
Behav Res Ther. 2011 Sep;49(9):536-43
pubmed: 21723534
Appetite. 2012 Feb;58(1):88-97
pubmed: 21983051
Clin Psychol Rev. 2012 Jun;32(4):343-57
pubmed: 22504491
Curr Psychiatry Rep. 2012 Aug;14(4):432-46
pubmed: 22707016
Behav Res Ther. 2012 Dec;50(12):775-85
pubmed: 23099111
Trials. 2012 Nov 21;13:220
pubmed: 23171536
Biol Psychiatry. 2013 May 1;73(9):904-14
pubmed: 23290497
Int J Eat Disord. 2013 Jul;46(5):508-15
pubmed: 23658102
Int J Eat Disord. 2013 Sep;46(6):539-52
pubmed: 23674367
BMC Psychiatry. 2013 Aug 06;13:207
pubmed: 23919625
Psychiatr Prax. 2013 Sep;40(6):321-6
pubmed: 24008680
Curr Opin Psychiatry. 2013 Nov;26(6):543-8
pubmed: 24060914
Curr Opin Psychiatry. 2013 Nov;26(6):549-55
pubmed: 24060917
Behav Med. 2015;41(2):60-8
pubmed: 24354470
Behav Res Ther. 2014 Jul;58:36-42
pubmed: 24929926
BMC Med Inform Decis Mak. 2014 Jul 23;14:60
pubmed: 25056379
Behav Res Ther. 2014 Oct;61:55-60
pubmed: 25133855
J Med Internet Res. 2015 Mar 31;17(3):e85
pubmed: 25840591
World Psychiatry. 2015 Oct;14(3):270-7
pubmed: 26407772
World Psychiatry. 2015 Oct;14(3):310-1
pubmed: 26407786
J Clin Psychiatry. 2016 Aug;77(8):e968-74
pubmed: 27232527
PLoS One. 2016 Jun 22;11(6):e0157503
pubmed: 27331907
Behav Res Ther. 2016 Sep;84:9-13
pubmed: 27423373
Curr Opin Psychiatry. 2016 Nov;29(6):340-5
pubmed: 27662598
J Clin Psychiatry. 2017;78 Suppl 1:20-24
pubmed: 28125175
Int J Eat Disord. 2017 Mar;50(3):190-209
pubmed: 28134980
Am J Psychiatry. 2017 Feb 1;174(2):91-92
pubmed: 28142273
JAMA Psychiatry. 2017 Oct 1;74(10):987-995
pubmed: 28768334
Clin Psychol Psychother. 2018 Mar 23;:null
pubmed: 29573144
Control Clin Trials. 1988 Dec;9(4):365-74
pubmed: 3203526

Auteurs

Simone Munsch (S)

Department of Clinical Psychology and Psychotherapy, University of Fribourg, Rue de Faucigny 2, 1700, Fribourg, Switzerland. simone.munsch@unifr.ch.

Andrea Wyssen (A)

Department of Clinical Psychology and Psychotherapy, University of Fribourg, Rue de Faucigny 2, 1700, Fribourg, Switzerland.

Pierre Vanhulst (P)

Human-IST Institute, University of Fribourg, Boulevard de Perolles 90, 1700, Fribourg, Switzerland.

Denis Lalanne (D)

Human-IST Institute, University of Fribourg, Boulevard de Perolles 90, 1700, Fribourg, Switzerland.

Sharon T Steinemann (ST)

Department of General Psychology and Methodology, University of Basel, Missionsstrasse 62a, 4055, Basel, Switzerland.

Alexandre Tuch (A)

Department of General Psychology and Methodology, University of Basel, Missionsstrasse 62a, 4055, Basel, Switzerland.
Swiss Health Observatory, Federal Statistical Office, Espace de l'Europe 10, 2010, Neuchâtel, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH